Rectified Flow For Structure Based Drug Design

• URL: http://arxiv.org/abs/2412.01174v1
• Date: Mon, 02 Dec 2024 06:26:25 GMT
• Title: Rectified Flow For Structure Based Drug Design
• Authors: Daiheng Zhang, Chengyue Gong, Qiang Liu,
• Abstract summary: Deep generative models have achieved tremendous success in structure-based drug design. New framework FlowSBDD allows us to flexibly incorporate additional loss to optimize specific target. Our approach could achieve state-of-the-art performance on generating high-affinity molecules.
• Score: 26.08743098507441
• License:
• Abstract: Deep generative models have achieved tremendous success in structure-based drug design in recent years, especially for generating 3D ligand molecules that bind to specific protein pocket. Notably, diffusion models have transformed ligand generation by providing exceptional quality and creativity. However, traditional diffusion models are restricted by their conventional learning objectives, which limit their broader applicability. In this work, we propose a new framework FlowSBDD, which is based on rectified flow model, allows us to flexibly incorporate additional loss to optimize specific target and introduce additional condition either as an extra input condition or replacing the initial Gaussian distribution. Extensive experiments on CrossDocked2020 show that our approach could achieve state-of-the-art performance on generating high-affinity molecules while maintaining proper molecular properties without specifically designing binding site, with up to -8.50 Avg. Vina Dock score and 75.0% Diversity.

Related papers

• Masked Autoencoders Are Effective Tokenizers for Diffusion Models [56.08109308294133]
  MAETok is an autoencoder that learns semantically rich latent space while maintaining reconstruction fidelity. MaETok achieves significant practical improvements, enabling a gFID of 1.69 with 76x faster training and 31x higher inference throughput for 512x512 generation.
  arXiv  Detail & Related papers  (2025-02-05T18:42:04Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• AUTODIFF: Autoregressive Diffusion Modeling for Structure-based Drug Design [16.946648071157618]
  We propose a diffusion-based fragment-wise autoregressive generation model for structure-based drug design (SBDD) We design a novel molecule assembly strategy named conformal motif that preserves the conformation of local structures of molecules first. We then encode the interaction of the protein-ligand complex with an SE(3)-equivariant convolutional network and generate molecules motif-by-motif with diffusion modeling.
  arXiv  Detail & Related papers  (2024-04-02T14:44:02Z)
• DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization [49.85944390503957]
  DecompOpt is a structure-based molecular optimization method based on a controllable and diffusion model. We show that DecompOpt can efficiently generate molecules with improved properties than strong de novo baselines.
  arXiv  Detail & Related papers  (2024-03-07T02:53:40Z)
• DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
  Existing structured-based drug design methods treat all ligand atoms equally. We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold. Our approach achieves state-of-the-art performance in generating high-affinity molecules.
  arXiv  Detail & Related papers  (2024-02-26T05:21:21Z)
• Navigating the Design Space of Equivariant Diffusion-Based Generative Models for De Novo 3D Molecule Generation [1.3124513975412255]
  Deep generative diffusion models are a promising avenue for 3D de novo molecular design in materials science and drug discovery. We explore the design space of E(3)-equivariant diffusion models, focusing on previously unexplored areas. We present the EQGAT-diff model, which consistently outperforms established models for the QM9 and GEOM-Drugs datasets.
  arXiv  Detail & Related papers  (2023-09-29T14:53:05Z)
• Protein Design with Guided Discrete Diffusion [67.06148688398677]
  A popular approach to protein design is to combine a generative model with a discriminative model for conditional sampling. We propose diffusioN Optimized Sampling (NOS), a guidance method for discrete diffusion models. NOS makes it possible to perform design directly in sequence space, circumventing significant limitations of structure-based methods.
  arXiv  Detail & Related papers  (2023-05-31T16:31:24Z)
• Structure-based Drug Design with Equivariant Diffusion Models [40.73626627266543]
  We present DiffSBDD, an SE(3)-equivariant diffusion model that generates novel conditioned on protein pockets. Our in silico experiments demonstrate that DiffSBDD captures the statistics of the ground truth data effectively. These results support the assumption that diffusion models represent the complex distribution of structural data more accurately than previous methods.
  arXiv  Detail & Related papers  (2022-10-24T15:51:21Z)
• A Survey on Generative Diffusion Model [75.93774014861978]
  Diffusion models are an emerging class of deep generative models. They have certain limitations, including a time-consuming iterative generation process and confinement to high-dimensional Euclidean space. This survey presents a plethora of advanced techniques aimed at enhancing diffusion models.
  arXiv  Detail & Related papers  (2022-09-06T16:56:21Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.